![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 09, 2014 4:13:37 PM
(e) Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will not sell, transfer, assign, hypothecate or otherwise dispose of any Securities or any direct or indirect interest therein for a period of sixty (60) days following the Closing Date.
The company itself is also restricted to maintain enough shares for issuance to satisfy the amount of common stock that would be issued for conversion, that is subject to change dependent upon the common stock value, furthermore based upon the stated value of the preferred share price of $100 per share. The warrants for common stock that may be issued are subject to the R/S terms, but are also subject to recent closing prices of the share value. This also means that the more dilution they participate in, to the detriment of the share price would result in the necessity for them to maintain the shares necessary, at a minimum, for compensation of preferred stock conversion of their original investment. So no matter the math we attempt now, it can change within the next day, or week. So to avoid the impact on PPS that would effect the company to maintain a higher amount of shares available, the company is limited in their capability to dilute, as to maintain a high enough unissued share availability to satisfy these terms of the agreement. The company is also restricted from further private placement share issuance without approvals of Dr. Edery, and appointed board members, or risk further need to increase A/S issuance to maintain the preferred share control Dr. Edery and aggregate investors have purchased. So the company may have some share availability for issuance, but not without maintaining the proper amount to compensate investors until 2018. So this, in itself, limits their availability of shares to sell into the open market. It is a variable price rate, not only fixed to the amount of shares currently held. So go ahead and crunch the numbers every day, if you would like, but the restrictions are still in place to avoid such ostentatious dilution actions. If the company were to commit such action, then we would get proper notification of new registration of securities for an increase to A/S. The preferred share allowance for new investors is not necessarily a "moot point" either, considering the possibility of higher investor purchase that would require even more shares to be retained by the company for the case of any further conversion requirement. Also, if any investors were to liquidate shares, it would also entitle the other parties involved the same conversion price calculated for the purpose of conversion and sales. This, too, restricts the company from being foolish enough to dilute common shares into the open market that may risk further loss of value to investors, that they would be forced to compensate. Also, the fact that Edery maintains 3 members on the board (unless he sells below 25% control) assists in protecting his investment in management and fund raising decisions. Either way, if they decide to dilute and force an increase in S/S, then we will be notified of this occurrence by filings. There is always the possibility, but the controls in place decrease the probability of such actions.
I apologize for the delayed response. I had some other business to tend to this morning.
Recent DRIO News
- Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1 • PR Newswire (US) • 06/25/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:02:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:01:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 12:30:15 PM
- Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer • PR Newswire (US) • 06/05/2024 12:30:00 PM
- DarioHealth Reports First Quarter 2024 Financial and Operating Results • PR Newswire (US) • 05/15/2024 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 10:06:09 AM
- DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th • PR Newswire (US) • 05/07/2024 12:30:00 PM
- Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes • PR Newswire (US) • 04/25/2024 12:30:00 PM
- Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution • PR Newswire (US) • 04/18/2024 12:30:00 PM
- Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health • PR Newswire (US) • 04/10/2024 12:30:00 PM
- Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health • PR Newswire (US) • 04/02/2024 12:30:00 PM
- DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results • PR Newswire (US) • 03/28/2024 10:30:00 AM
- DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH • PR Newswire (US) • 03/21/2024 12:30:00 PM
- New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications • PR Newswire (US) • 03/12/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:24:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:23:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:21:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:20:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:19:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:16:57 PM
- DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE • PR Newswire (US) • 02/28/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:05:57 PM
FEATURED BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • Jul 2, 2024 7:19 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM